Search Results for ""drugs for""
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for "drugs for". Results 2551 to 2560 of 2585 total matches.
Lasers Treatment of Cutaneous Vascular Abnormalities
The Medical Letter on Drugs and Therapeutics • Nov 01, 1991 (Issue 856)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
In recent years, the availability of new types of lasers has improved the treatment of disfiguring cutaneous vascular abnormalities. Vascular lesions of the skin that can be treated with lasers include port-wine stains, telangiectases, and strawberry hemangiomas (RA Silverman, Pediatr Clin North Am, 38:811, Aug 1991).
Laser Hair Removal
The Medical Letter on Drugs and Therapeutics • Jul 30, 1999 (Issue 1058)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
A long-pulse ruby laser (EpiLaser), has been cleared by the FDA for use in "permanent hair reduction."
Phytoestrogens
The Medical Letter on Drugs and Therapeutics • Feb 21, 2000 (Issue 1072)
The Medical Letter
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 1000 Main ...
Phytoestrogens, plant compounds that are converted to estrogens in the gut, are widely promoted as "natural"substitutes for estrogen in hormone replacement therapy.
Automated External Defibrillators
The Medical Letter on Drugs and Therapeutics • Dec 11, 2000 (Issue 1094)
The Medical Letter
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 1000 Main ...
Recent studies suggest that timely use of automated external defibrillators operated by laypersons with minimal training can save lives. Purchase of these devices for public places or home use requires authorization from a physician.
A New Snake Antivenom
The Medical Letter on Drugs and Therapeutics • Jun 25, 2001 (Issue 1107)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
CroFab, an antigen-binding-fragment (Fab) antivenom of ovine origin, has been approved by the FDA for treatment of North American rattlesnake envenomation.
Private Cord Blood Banks
The Medical Letter on Drugs and Therapeutics • Mar 15, 2004 (Issue 1178)
.
21
The Medical Letter
®
On Drugs and Therapeutics
www.medicalletter.org
Published by The Medical ...
Private cord blood banks continue to advertise their services to couples expecting a child. Cord blood can be stored safely for many years. Public cord blood banks accept collections only from affiliated hospitals (Medical Letter 2001; 43:84). Units are available for any patient; there is no guarantee that a particular donor's blood will be available if the donor or a family member needs a stem cell transplant. Many patients can find an unrelated match in a public cord blood bank, but members of minority ethnic groups are often more difficult to match (www.marrow.org). Private cord blood banks...
Epidural Corticosteroid Injections for Lumbar and Cervical Radiculopathy
The Medical Letter on Drugs and Therapeutics • Jan 23, 2012 (Issue 1382)
Letter®
On Drugs and Therapeutics
Volume 54 (Issue 1382)
January 23, 2012
www.medicalletter.org ...
For patients with radicular pain unresponsive to conservative
treatment after 1-2 months and no progressive
neurologic deficit, epidural corticosteroid
injections are often tried before surgical intervention.
Minimed 670G: A Hybrid Closed-Loop Insulin Delivery System
The Medical Letter on Drugs and Therapeutics • Nov 21, 2016 (Issue 1508)
: an insulin pump with low-glucose suspend automation.
Med Lett Drugs Ther 2013; 55:97.
2. FDA. Minimed 670G ...
The FDA has approved the Minimed 670G (Medtronic),
a hybrid closed-loop insulin delivery system for use in
patients ≥14 years old with type 1 diabetes. The system
uses an algorithm to automatically adjust basal insulin
doses based on readings from a continuous glucose
monitor (CGM). It fully automates basal insulin
delivery in "auto" mode, but is considered a "hybrid"
system (not a true "artificial pancreas") because it
requires some action by the patient. The 670G system
is expected to become available in Spring 2017.
COVID-19 Update: Bivalent Pfizer and Moderna COVID-19 Vaccines for Booster Immunization
The Medical Letter on Drugs and Therapeutics • Oct 03, 2022 (Issue 1660)
at:
www.medicalletter.org/drugs-for-covid-19.
Moderna vaccine (≥18 years old) ≥2 months after their
most recent monovalent ...
The FDA has amended its Emergency Use Authorizations
(EUAs) for the mRNA COVID-19 vaccines
manufactured by Pfizer/BioNTech (Comirnaty)
and Moderna (Spikevax) to permit use of bivalent
formulations of the products as a single booster dose
in persons ≥12 years old (Pfizer) or ≥18 years old
(Moderna) whose most recent COVID-19 vaccine dose
was a monovalent product given ≥2 months previously
as a booster or for completion of a primary series. The
bivalent formulations are not authorized for primary
immunization. Monovalent Pfizer and Moderna
COVID-19 vaccines are no longer...
Screening For Lung Cancer
The Medical Letter on Drugs and Therapeutics • Jul 23, 2001 (Issue 1109)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Most patients with lung cancer present with advanced disease, and fewer than 20% live for five years after diagnosis. Earlier detection of lung cancer, when it is potentially resectable, might improve survival. Recent studies have led some radiology centers to promote spiral computed tomography (CT), which involves much less exposure to radiation than standard CT, as a screening tool for lung cancer.